Symposium L11: NAFLD / MAFLD SIG Programme 3

Symposium L11: NAFLD / MAFLD SIG Programme 3

22 Aug 2021 12:00 13:30

Join Now

Chan Wah-Kheong Chair

George Goh Boon-Bee Chair

Vincent Wong Wai-Sun Chair

Time	Session

12:00 12:12	Novel Biomarkers for NASH and Fibrosis (12 mins) Leon Adams Speaker
12:12 12:24	Endpoints in Clinical Trials: What Counts and Why? (12 mins) Vincent Wong Wai-Sun Speaker
12:24 12:36	Patient Reported Outcomes and Its Place in NASH Research and Drug Development (12 mins) Zobair Younossi Speaker
12:36 12:48	Emerging Therapy for NASH: Targeting Metabolism (12 mins) Vlad Ratziu Speaker
12:48 13:00	Emerging Therapy for NASH: Targeting Fibrosis (12 mins) Arun Sanyal Speaker
13:00 13:12	Precision Medicine in NAFLD – A Glance Into the Future (12 mins) Scott Friedman Speaker
13:12 13:30	Q&A and Live Discussion (18 mins)

Platinum Sponsor

Gold Sponsors

Silver Sponsors

Organised By
Hosted By

Presented by

Asian Pacific Association of Gastroenterology
Asian Pacific Association for Study of the Liver
Asian Pacific Society of Digestive Endoscopy
International Society for Digestive Surgery – Asian Pacific

Endorsed By

American Society for Gastrointestinal Endoscopy

Stay tuned! Don't miss an update from APDW 2021

For any enquiry e-mail at secretariat@apdwkl2021.org